China Reinsurance(Group)Corp (1508)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 1.180 |
|---|---|
| 52-week range | 1.023 – 1.712 |
| Return, 1 month / 3 months | −2.5% / −3.3% |
| Return, 1 year / 3 years | −19.7% / +191.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 34.2% |
| Worst drawdown (1 year) | -38.3% |
| Average daily value traded | 13.86M HKD |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Reinsurance (Group) Corporation is a reinsurance group based in Beijing. It provides reinsurance cover to insurance companies, writing property and casualty reinsurance and life reinsurance through its specialist subsidiaries. The group also carries on primary insurance business and manages assets. Its customers are insurers and other institutions in China and in overseas markets, and it operates through a network of branches and subsidiaries serving those clients.
On this site China Reinsurance(Group)Corp appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 1508, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Reinsurance(Group)Corp (1508) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 1.180 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 707 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 19.7% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -30.7% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.3% | ||
| 6-month return | -8.7% | ||
| 12-month return, skipping the last month | -17.7% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.3% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 13.86M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.6% |
|---|---|
| 1 month | −2.5% |
| 3 months | −3.3% |
| 6 months | −8.7% |
| 1 year | −19.7% |
| 3 years | +191.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.234 / 1.327 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.035 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Jun 2026 | HKD 0.0795 |
| 2 Jul 2025 | HKD 0.0548 |
| 3 Jul 2024 | HKD 0.0460 |
| 29 Jun 2023 | HKD 0.0153 |
| 27 Jun 2022 | HKD 0.0527 |
| 29 Jun 2021 | HKD 0.0492 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.